Rapid onset opioids in palliative medicine
- PMID: 25841429
- DOI: 10.3978/j.issn.2224-5820.2012.01.01
Rapid onset opioids in palliative medicine
Abstract
Opioids are potent broad-spectrum analgesics useful to treat a variety of painful conditions. Opioids have been classified by many different categorizations (e.g. natural, semisynthetic, synthetic). One classification that may be useful in terms of selecting specific opioid agents is based on the pharmacokinetic characteristics of the various opioid formulations (e.g. longacting opioids, short-acting opioids, and rapid onset opioids). These various opioid agents appear to be useful to "match" specific types of pains. Rapid onset opioids appear especially well-suited to treat breakthrough pain and in particular, rapidonset breakthrough pain. This article will briefly review 5 rapid onset opioids that are FDA approved in the U.S.
Keywords: Breakthrough; fentanyl; opioids; pain; rapid onset.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.J Pain Symptom Manage. 2014 Jun;47(6):990-1000. doi: 10.1016/j.jpainsymman.2013.07.006. Epub 2013 Oct 5. J Pain Symptom Manage. 2014. PMID: 24099893 Clinical Trial.
-
What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.Pain Pract. 2009 Nov-Dec;9(6):468-79. doi: 10.1111/j.1533-2500.2009.00320.x. Pain Pract. 2009. PMID: 19874536 Review.
-
A review of rapid-onset opioids for breakthrough pain in patients with cancer.J Opioid Manag. 2014 May-Jun;10(3):207-15. doi: 10.5055/jom.2014.0209. J Opioid Manag. 2014. PMID: 24944071 Review.
-
Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.Pain Med. 2010 Jul;11(7):1024-36. doi: 10.1111/j.1526-4637.2010.00891.x. Pain Med. 2010. PMID: 20642730 Review.
Cited by
-
Abuse potential of fentanyl and fentanyl analogues.Bioimpacts. 2024;14(6):27691. doi: 10.34172/bi.2024.27691. Epub 2024 Mar 18. Bioimpacts. 2024. PMID: 39493900 Free PMC article.
-
Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1189-1197. doi: 10.15585/mmwr.mm6935a1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32881854 Free PMC article.
-
Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis.Clin Drug Investig. 2019 May;39(5):455-462. doi: 10.1007/s40261-019-00767-8. Clin Drug Investig. 2019. PMID: 30852809
-
Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blind, placebo-controlled study.J Anesth. 2012 Oct;26(5):752-7. doi: 10.1007/s00540-012-1421-7. Epub 2012 Jun 7. J Anesth. 2012. PMID: 22674156 Clinical Trial.
LinkOut - more resources
Full Text Sources
